Dr. Jordan Orange to lead newly merged program in pediatric Immunology, Allergy and Rheumatology at Texas Children’s Hospital and Baylor College of Medicine
HOUSTON, May 9, 2012 /PRNewswire-USNewswire/ — Texas Children’s Hospital and Baylor College of Medicine (BCM) announced the arrival of Dr. Jordan Orange to lead a newly merged section and service of Immunology, Allergy and Rheumatology. An internationally recognized leader in studying and treating primary immunodeficiency disorders in children, Orange serves as chief of Immunology, Allergy and Rheumatology and director of a new Center for Human Immunobiology at Texas Children’s and as professor and section head for Immunology, Allergy and Rheumatology in the Department of Pediatrics at BCM.
Orange’s research focuses on the biology of natural killer cells and the innate immune system, with a clinical focus on primary immunodeficiency disease. He has received funding from the National Institute of Allergy and Infectious Diseases, as well as the United States Immunodeficiency Network to support his laboratory work.
Over the past decade, Orange has redefined the field of human natural killer cell deficiencies in various genetic disorders. He recently collaborated with European researchers who achieved marked clinical improvements in using gene therapy to treat young children with Wiskott-Aldrich syndrome, a rare but often severe immunodeficiency disorder. He is currently conducting clinical trials testing the use of immunotherapy to boost immune function in children with Wiskott-Aldrich syndrome.
“Dr. Orange is an outstanding physician-scientist who will provide extraordinary leadership to our newly merged program in pediatric Immunology, Allergy and Rheumatology,” said Dr. Mark Kline, physician-in-chief at Texas Children’s Hospital and professor and chairman of the Department of Pediatrics at BCM. “The cutting-edge research he brings to Texas Children’s and BCM stands to transform the treatment and prognosis of a whole range of primary immunodeficiency diseases that impact children’s health.”
Orange comes to Texas Children’s and BCM from the Children’s Hospital of Philadelphia and the University of Pennsylvania where he served as the Jeffrey Modell Endowed Chair in Immunology. He is a National Institutes of Health R01-funded investigator and is one of the world’s leading physician-scientists studying the pathogenesis and treatment of primary immunodeficiency disease.
Orange obtained his undergraduate, M.D. and Ph.D. degrees from Brown University and completed his pediatric residency training at the Children’s Hospital of Philadelphia, followed by postdoctoral fellowship training in pediatric allergy/immunology and rheumatology at Children’s Hospital Boston and Harvard University.
Orange has authored more than 100 peer-reviewed papers, the majority of which have been published in top-tier journals including the New England Journal of Medicine, Nature, Journal of Clinical Investigation, Journal of Experimental Medicine and Journal of Immunology, among others. He is an elected member of the American Society of Clinical Investigation and has been invited to present at dozens of national and international meetings. He has also won numerous national awards, including the 2009 American Philosophical Society Judson Daland Prize, which honors outstanding achievements in patient-oriented research.
About Texas Children’s Hospital
Texas Children’s Hospital is committed to a community of healthy children by providing the finest pediatric patient care, education and research. Renowned worldwide for its expertise and breakthrough developments in clinical care and research, Texas Children’s is nationally ranked in all 10 subspecialties in U.S.News & World Report‘s list of Best Children’s Hospitals. Texas Children’s also operates the nation’s largest primary pediatric care network, with more than 40 offices throughout the greater Houston community. Texas Children’s has embarked on a $1.5 billion expansion, Vision 2010, which includes the Jan and Dan Duncan Neurological Research Institute, a comprehensive obstetrics facility focusing on high-risk births and a community hospital in suburban West Houston. For more information on Texas Children’s Hospital, go to www.texaschildrens.org. Get the latest news from Texas Children’s Hospital by visiting the online newsroom and on Twitter at twitter.com/texaschildrens.
Contact: Jenn Blackmer
SOURCE Texas Children’s Hospital